Celebrating a 10 year partnership: ecancer and the IEO
Celebrating a 10 year partnership: ecancer and the IEO
Measuring Success in Indolent Disease: Discuss, Debate, Decide
What’s important to patients in a non-curative setting?
What to do when standard treatment fails?
How do we measure treatment success?
New drugs on the horizon for pancreatic cancer
Neo-adjuvant/adjuvant treatment in gastric cancer
Recommendations for surveillance of adenomas
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Implementation of a wait and see program for rectal cancer
Cholangiocarcinoma and gallbladder cancer